Literature DB >> 31406488

Cavernous sinus haemangioma with intrasellar extension mimicking non-functioning pituitary adenoma - A case report and review of literature.

Dorota Księżniak-Baran1, Sławomir Blamek2, Agata Roch-Zniszczoł2, Wojciech Osewski3, Maja Jędrzejewska4.   

Abstract

Fifty-three-year-old male suffering from a presumptive non-functioning pituitary adenoma was qualified for stereotactic radiosurgery in our institution. Two attempts of surgical treatment were taken three months before radiotherapy. Excessive bleeding did not allow to remove the tumour or to take samples for histopathological examination. Diagnosis was put on the basis of radiological assessment and lack of hypersecretion of pituitary hormones. However, radiological reevaluation in our Institute revealed the presence of a well-bounded tumour invading the cavernous sinus with high contrast enhancement in FLAIR and T2-sequence. Moreover, a constriction of the normal pituitary gland with tumour mass was seen. The imaging features of the lesion finally led to diagnosis of cavernous sinus haemangioma with intrasellar expansion. The patient received radiosurgical treatment with the use of linear accelerator (LINAC). A dose of 7 Gy in one fraction was administered to achieve satisfactory local control, prevent potential further bleeding and reduce the risk of progressive neurological deficits. Stable size of the tumour and absence of any complications are confirmed in six years of follow-up.

Entities:  

Keywords:  Cavernous sinus; Haemangioma; Pituitary adenoma; Radiosurgery; Stereotactic radiotherapy

Year:  2019        PMID: 31406488      PMCID: PMC6685642          DOI: 10.1016/j.rpor.2019.07.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  20 in total

1.  Radiosurgical treatment of cavernous sinus cavernous haemangiomas.

Authors:  S Peker; T Kiliç; M Sengöz; M N Pamir
Journal:  Acta Neurochir (Wien)       Date:  2004-02-25       Impact factor: 2.216

2.  Intrasellar cavernous hemangioma.

Authors:  Chi-Cheng Chuang; Shih-Ming Jung; Jen-Tsung Yang; Chen-Nen Chang; Ping-Ching Pai
Journal:  J Clin Neurosci       Date:  2006-07-11       Impact factor: 1.961

3.  Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients.

Authors:  Kang-Du Liu; Wen-Yuh Chung; Hsiu-Mei Wu; Cheng-Ying Shiau; Ling-Wei Wang; Wan-You Guo; David Hung-Chi Pan
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

4.  Merits of intralesional fibrin glue injection in surgery for cavernous sinus cavernous hemangiomas. Technical note.

Authors:  Il-Man Kim; Man-Bin Yim; Chang-Young Lee; Eun-Ik Son; Dong-Won Kim; Sang-Pyo Kim; Chul-Ho Sohn
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

Review 5.  Are cavernous sinus hemangiomas and cavernous malformations different entities?

Authors:  L Fernando Gonzalez; Gregory P Lekovic; Jennifer Eschbacher; Stephen Coons; Randall W Porter; Robert F Spetzler
Journal:  Neurosurg Focus       Date:  2006-07-15       Impact factor: 4.047

6.  Radiosurgery of cavernous hemangiomas in the cavernous sinus.

Authors:  Y Kida; T Kobayashi; Y Mori
Journal:  Surg Neurol       Date:  2001-08

7.  Non-meningeal tumours of the cavernous sinus: a surgical analysis.

Authors:  M Necmettin Pamir; Türker Kilic; M Memet Ozek; Koray Ozduman; Uğur Türe
Journal:  J Clin Neurosci       Date:  2006-07       Impact factor: 1.961

Review 8.  Diagnosis and surgical treatment of cavernous sinus hemangiomas: an experience of 20 cases.

Authors:  Liang-Fu Zhou; Ying Mao; Liang Chen
Journal:  Surg Neurol       Date:  2003-07

9.  Tumors of the lateral wall of the cavernous sinus.

Authors:  M el-Kalliny; H van Loveren; J T Keller; J M Tew
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

10.  Juxtaposition of an epidural intraforaminal cavernous hemangioma and an intradural schwannoma.

Authors:  Claudius Thomé; Dimitris Zevgaridis; Dejana Matejic; Clemens Sommer; Joachim K Krauss
Journal:  Spine (Phila Pa 1976)       Date:  2004-11-15       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.